Health Care & Life Sciences » Biotechnology | OncoTherapy Science Inc.

OncoTherapy Science Inc. | Mutual Funds

Mutual Funds that own OncoTherapy Science Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Siemens Global Growth
352,546
0.24%
11,500
0.41%
04/30/2018
Monega Innovation
123,000
0.08%
0
0.28%
07/31/2018
SPDR S&P World (ex-US) ETF
84,900
0.06%
400
0%
09/06/2018
CREF Stock Account
69,100
0.05%
0
0%
03/31/2018
SPDR S&P International Small Cap ETF
51,700
0.04%
0
0.01%
09/06/2018
Amundi (Japan) Resona Japan Growth Strategic Equity Open
45,920
0.03%
45,920
0.28%
04/25/2017
15,100
0.01%
0
0%
12/29/2017
3,800
0%
0
0%
01/31/2018
Vanguard Investment Series Plc - Global Small Cap Index Fund
0
0%
-21,350
0%
07/31/2018
GO UCITS ETF Solutions Plc - Longer Dated All Commodities
0
0%
-112,700
0%
02/28/2018

About OncoTherapy Science

View Profile
Address
Kanagawa Science Park R&D D Bldg.
Kawasaki Kanagawa 213
Japan
Employees -
Website http://www.oncotherapy.co.jp
Updated 07/08/2019
OncoTherapy Science, Inc. engages in the research and development of pharmaceutical products. It focuses its research on cancer-related cells and genes, and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine and nucleic acid drugs. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.